Advertisement

Annals of Surgical Oncology

, Volume 4, Issue 6, pp 491–495 | Cite as

Epithelioid sarcoma: Clinical behavior and prognostic factors of survival

  • Howard M. Ross
  • Jonathan J. Lewis
  • James M. Woodruff
  • Murray F. Brennan
Original Articles

Abstract

Background: Epithelioid sarcoma is a rare histologic subtype of sarcoma. The clinical behavior and prognostic factors influencing survival in this disease are examined.

Methods: A review of clinicopathologic features of patients with epithelioid sarcoma prospectively followed between July 1982 and July 1995 at Memorial Sloan-Kettering Cancer Center was performed. Kaplan-Meier and log-rank analysis were used.

Results: Eleven men (69%) and five women (31%) were treated during this period. Mean age at diagnosis was 33 years, and length of symptoms before diagnosis was 18 months. Tumors presented in the trunk in 44% of patients, the lower extremity in 31%, and the upper extremity in 25%. Median follow-up time was 45 months. At least one local recurrence was experienced by 69% of patients. Metastases to regional lymph nodes during the course of the disease developed in 44% of patients and to the lungs in 44%. Median survival was 88.8 months, with a 66% 5-year survival rate. Pulmonary metastasis was correlated with decreased survival.

Conclusions: A delay in diagnosis of epithelioid sarcoma is common. Epithelioid sarcoma differs from other sarcoma subtypes in propensity for nodal spread and local recurrence. Careful follow-up evaluating local recurrence, nodal spread, and pulmonary metastases is warranted.

Key Words

Epithelioid sarcoma Sarcoma treatment Review 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Chase DR, Enzinger FM. Epithelioid sarcoma: diagnosis, prognostic indicators, and treatment.Am J Surg Pathol 1985;9:241–63.PubMedGoogle Scholar
  2. 2.
    Prat J, Woodruff JM, Marcove R. Epithelioid sarcoma: an analysis of 22 cases indicating the prognostic significance of vascular invasion and regional lymph node metastasis.Cancer 1978;41:1472–87.PubMedGoogle Scholar
  3. 3.
    Fong Y, Coit DG, Woodruff JF, Brennan MF. Lymph node metastasis from soft tissue sarcoma in adults.Ann Surg 1992;217:72–7.Google Scholar
  4. 4.
    Harrison LB, Franzese F, Gaynor JJ, Brennan MF. Long term results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk.Int J Radiat Oncol Biol Phys 1993;27:259–25.PubMedGoogle Scholar
  5. 5.
    Bos GD, Pritchard DJ, Reiman HM, Dobyns JH, Ilstrup DM, Landon GC. Epithelioid sarcoma: an analysis of fifty-one cases.J Bone Joint Surg [Am] 1988;70:862–70.PubMedGoogle Scholar
  6. 6.
    Enzinger FM. Epithelioid sarcoma: a sarcoma simulating a granuloma or carcinoma.Cancer 1970;26:1029–41.PubMedGoogle Scholar
  7. 7.
    Gallup DG, Abell MR, Morley GW. Epithelioid sarcoma of the vulva.Obstet Gynecol 1976;48(suppl):14–17.Google Scholar
  8. 8.
    Hall DJ, Grimes MM, Goplerud DR. Epithelioid sarcoma of the vulva.Gynecol Oncol 1980;9:237–46.CrossRefPubMedGoogle Scholar
  9. 9.
    Konefka T, Senkus E, Emerich J, Dudziak M. Epithelioid sarcoma of the Bartholin's gland primarily diagnosed as vulvar carcinoma.Gynecol Oncol 1994;54:393–5.CrossRefPubMedGoogle Scholar
  10. 10.
    Moore SW, Wheeler JE, Hefter LG. Epithelioid sarcoma masquerading as Peyronie's disease.Cancer 1975;35:1706–10.PubMedGoogle Scholar
  11. 11.
    Gaynor JJ, Tan CC, Casper ES, et al. Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: a study of 423 adults.J Clin Oncol 1992;10:1317–29.PubMedGoogle Scholar
  12. 12.
    Geer RJ, Woodruff J, Casper ES, Brennan MF. Management of small soft-tissue sarcoma of the extremity in adults.Arch Surg 1992;127:1285–9.PubMedGoogle Scholar
  13. 13.
    Rosenberg SA, Tepper J, Glatstein E, et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation compared with amputation and (2) the role of adjuvant chemotherapy.Ann Surg 1982;196:305–15.PubMedGoogle Scholar
  14. 14.
    Williard WC, Hadju SI, Casper ES, Brennan MF. Comparison of amputation with limb-sparing operations for adult soft tissue sarcoma of the extremity.Ann Surg 1992;215:269–75.PubMedGoogle Scholar
  15. 15.
    Gadd MA, Casper ES, Woodruff JM, McCormack PM, Brennan MF. Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma.Ann Surg 1993;218:705–12.PubMedGoogle Scholar

Copyright information

© The Society of Surgical Oncology, Inc 1997

Authors and Affiliations

  • Howard M. Ross
    • 2
  • Jonathan J. Lewis
    • 2
  • James M. Woodruff
    • 1
  • Murray F. Brennan
    • 2
  1. 1.the Department of PathologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  2. 2.Dept. of SurgeryMemorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations